TR201620103A2 - İnhalasyon i̇le uygulanan formülasyonlar - Google Patents

İnhalasyon i̇le uygulanan formülasyonlar Download PDF

Info

Publication number
TR201620103A2
TR201620103A2 TR2016/20103A TR201620103A TR201620103A2 TR 201620103 A2 TR201620103 A2 TR 201620103A2 TR 2016/20103 A TR2016/20103 A TR 2016/20103A TR 201620103 A TR201620103 A TR 201620103A TR 201620103 A2 TR201620103 A2 TR 201620103A2
Authority
TR
Turkey
Prior art keywords
pharmaceutically acceptable
acceptable derivatives
present
group
chronic
Prior art date
Application number
TR2016/20103A
Other languages
English (en)
Inventor
Erten Başaran Fatma
Original Assignee
Fatma Erten Basaran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fatma Erten Basaran filed Critical Fatma Erten Basaran
Priority to TR2016/20103A priority Critical patent/TR201620103A2/tr
Publication of TR201620103A2 publication Critical patent/TR201620103A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş; astım, kronik ve akut bronşit, Kronik Obstruktif Akciğer Hastalığı (KOAH), amfizem gibi akciğer hastalıklarının profilaktik ve/veya semptomatik ve/veya terapötik tedavisinde kullanılmak üzere glukokortikoid grubunda yer alan uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevlerinin, uzun etkili selektif ß2-adrenerjik agonistleri grubunda yer alan uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevleri ile kombine tedavisini içeren farmasötik bileşim/ler ile ilgilidir.
TR2016/20103A 2016-12-29 2016-12-29 İnhalasyon i̇le uygulanan formülasyonlar TR201620103A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/20103A TR201620103A2 (tr) 2016-12-29 2016-12-29 İnhalasyon i̇le uygulanan formülasyonlar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/20103A TR201620103A2 (tr) 2016-12-29 2016-12-29 İnhalasyon i̇le uygulanan formülasyonlar

Publications (1)

Publication Number Publication Date
TR201620103A2 true TR201620103A2 (tr) 2018-07-23

Family

ID=64901710

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/20103A TR201620103A2 (tr) 2016-12-29 2016-12-29 İnhalasyon i̇le uygulanan formülasyonlar

Country Status (1)

Country Link
TR (1) TR201620103A2 (tr)

Similar Documents

Publication Publication Date Title
SA521430920B1 (ar) P2x3 مشتقات أمينو كينازولين كمثبطات
EP4620525A3 (en) Methods and compositions for treatment of pulmonary hypertension and other lung disorders
CY1120605T1 (el) Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης
BR112015006571A2 (pt) composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados
CU23284B7 (es) Tiotropium novedoso conteniendo polvo inhalador
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
MX377175B (es) Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc).
EP2682108A3 (en) Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
EP4591936A3 (en) Treatment of respiratory diseases
MX2022012359A (es) Formulacion.
ZA202212128B (en) Combination of alcaftadine and a corticosteroid
EP2682097A3 (en) Dry Powder Inhalers Comprising A Carrier Other Than Lactose
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
WO2011093820A3 (en) A pharmaceutical combination comprising tiotropium
MX373699B (es) Composicion farmaceutica que contiene budesonida y formoterol.
EA201201389A1 (ru) Ингалятор, создающий турбулентность
UY30935A1 (es) Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones.
WO2015049519A3 (en) Method and apparatus for making compositions for pulmonary administration
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
MX368036B (es) Particulas inhalables que comprenden tiotropio e indacaterol.
TR201620103A2 (tr) İnhalasyon i̇le uygulanan formülasyonlar
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
MX372705B (es) Composición farmacéutica que contiene budesonida y formoterol
TR201720846A2 (tr) Oral farmasöti̇k terki̇pler